Le Lézard
Classified in: Health, Science and technology
Subjects: SVY, TRI

PolyU Reveals High Prevalence of Bacteria that Carry the Colistin Resistance Gene mcr-1 in Human, Food and Environmental Samples


HONG KONG, December 8, 2017 /PRNewswire/ --

Food Safety and Technology Research Centre of the Department of Applied Biology and Chemical Technology (ABCT), The Hong Kong Polytechnic University (PolyU) recently found that bacteria that carry the colistin resistance gene mcr-1 commonly exist in human and various types of food and environmental samples collected from Hong Kong and the Chinese mainland. The mcr-1 gene is a new plasmid-encoded colistin resistance mechanism discovered by scientists in China in 2015. Colistin has been a last-resort antibiotic used to treat severe infections caused by carbapenem resistant Enterobacteriaceae (CRE) strains. The prevalence of mcr-1 in our ecosystem challenges the role of colistin as the last resort antibiotic to treat infections caused by CRE.

A novel method to isolate mcr-1-bearing bacteria and project a route of transmission 

Determining the origin of mcr-1 is important in assessing the degree of mcr-1 contamination, which can potentially impact the clinical use of colistin. However, there is lack of methods for specific isolation of mcr-1-positive bacteria, since many species of bacteria are intrinsically resistant to colistin, interfering with the isolation of mcr-1-positive organisms. Prof. Chen Sheng of ABCT has recently developed a sensitive and specific method for isolation of mcr-1-bearing bacteria from various sources and investigation of the prevalence of mcr-1 in various sample types.

Using this approach, Prof. Chen and his team found that mcr-1 was present in organisms recovered from human, a wide range of food and environment samples. The nature of distribution of mcr-1-bearing organisms in the test samples suggests that this resistance gene most likely originates from E. coli in the gastrointestinal (GI) tract of animals due to the prolonged usage of colistin in livestock as growth promoters. The mcr-1 gene might then be transmitted to humans through the food chain or direct contact between animals and humans, as well as through contamination of the fresh and seawater system, which in turn lead to the contamination of vegetables and seafood. The persistence of mcr-1 in the human GI tract microflora can cause further contamination of our water systems through improper disposal of wastewater containing human faeces. Pet animals which are rarely exposed to colistin exhibited a much lower level of prevalence of mcr-1-positive organisms than livestock. However, fresh water reservoir that is not contaminated by faeces was negative for mcr-1 gene.

Significance and implications of the findings 

Colistin has been effective in treatment of infections caused by CRE. However, since mcr-1-bearing, colistin resistant Enterobacteriaceae strains are extremely common in the ecosystem, the chance by which CRE strains acquire this highly prevalent mobile colistin resistance gene is much higher than we originally thought. An increasing prevalence of CRE strains which are also colistin resistant would lead to an increased rate of untreatable infections, especially among immune-compromised patients.

Prevention, diagnosis and treatment 

Given the prevalence of mcr-1 among Enterobacteriaceae strains in various environmental niches, increased usage of colistin to treat CRE infections may result in rapid selection of organisms that exhibit resistance to both carbapenems and colistin. Prof. Chen's findings highlight a need to develop effective inhibitors of MCR-1 or intervention measures that disrupt the transmission of mcr-1-bearing plasmids in order to preserve the value of colistin as a last-line antibiotic to treat life-threatening bacterial infections.

The study was published in Eurosurveillance, a journal published by the European Centre for Disease Prevention and Control (ECDC). The full article can be accessed via the link: http://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2017.22.39.17-00206

Press Contact 

Professor CHEN Sheng
Professor, Department of Applied Biology and Chemical Technology
Tel: +852-3400-8795
Email: [email protected]

SOURCE The Hong Kong Polytechnic University (PolyU)


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: